Article
Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes.
Clinica chimica acta; international journal of clinical chemistry - 1 Feb 2010
Strøm Thea Bismo, Holla Øystein L, Cameron Jamie, Berge Knut Erik, Leren Trond P
Abstract excerpt
OBJECTIVE: Published data may suggest that the cholesterol-lowering effect of mutation R46L in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene in familial hypercholesterolemia (FH) heterozygotes, is less pronounced than in normocholesterolemic subjects. METHODS: 1130 unrelated subj...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
